JAGX
JAGX
NASDAQ · Pharmaceuticals

Jaguar Health Inc

$2.71
+0.15 (+5.86%)
As of Jun 24, 6:05 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,667.5% upside
Low Target $35.39
Average Target $47.90
High Target $54.68
Current Price $2.71
Current
$2.71
Target
$47.90
$35.39 $47.90 avg $54.68
Scenario Analysis
Bear Case
$35.39
1,205.9%
Low target
Base Case
$47.90
+1,667.5%
Avg target
Bull Case
$54.68
+1,917.7%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$115.50
-97.7% from high
52-Week Low
$2.12
+27.8% from low
Target vs 52W High
$47.90
-58.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.4%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.7%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +31.4%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +40.7%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%